Back to search

Article

Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant Therapy

2020-03-20

Abstract excerpt

<title>Abstract</title> <p>Background: Studies reporting the results of associated factors of pathological completed response (PCR) and tumor regression response in patients with rectal cancer following neoadjuvant chemoradiation therapy (nCRT) are inconsistent. <h4>Objective:</h4> The purpose of this study was to identify the prognostic factors of tumor response and outcome in rectal cancer patients. <h4>Design:...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e421845f-9dd4-59fe-a939-34c2bb4b5136
DOI
10.21203/rs.3.rs-18119/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pathological Response Has Survival Benefits for Rectal Cancer following Neoadjuvant TherapyDOI 10.21203/rs.3.rs-18119/v1
An Integrated Model of Pathological Complete Response and Postoperative CEA Predicts Survival and Benefit of Adjuvant Chemotherapy for Locally Advanced Rectal CancerSemantic proximity
Factors Affecting Survival Prognosis of Patients with Rectal Cancer After Neoadjuvant ChemoradiotherapySemantic proximity
Impact of RAS/BRAF mutation status in locally advanced rectal cancer treated with preoperative chemotherapy.Semantic proximity
Five-year Survival Analyses on Non-Pathological Complete Response Esophageal Squamous Cell Carcinoma Patients after Neoadjuvant Regimens plus Surgery: a Propensity Score Matching, Real-World Cohort StudySemantic proximity
Neoadjuvant Chemotherapy plus Bevacizumab Combined with Total Mesorectal Excision in Treating Locally Advanced Rectal Cancer Patients with BRAF Mutation: Clinical Benefit and Safety.Semantic proximity
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative ChemoradiotherapySemantic proximity
Molecular differentiation between complete and incomplete responders to neoadjuvant therapy in rectal cancerSemantic proximity
Exploring novel inflammation-related genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancerSemantic proximity
Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer.Semantic proximity
Multi-dataset study on neoadjuvant treatment-related prognostic model and molecular network mechanism of locally advanced rectal cancerSemantic proximity
Local Tuning of Radiomics-Based Model for Predicting Pathological Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal CancerSemantic proximity
Tumor Resectability and Pathologic Response After Neoadjuvant Long-Course Chemoradiotherapy for Locally Advanced Rectal Cancer in a Resource-Limited SettingSemantic proximity
Select a neighboring publication to make it the new centre.